Back to Search Start Over

Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.

Authors :
Wang, Zuo-Teng
Li, Kun-Yan
Tan, Chen-Chen
Xu, Wei
Shen, Xue-Ning
Cao, Xi-Peng
Wang, Ping
Bi, Yan-Lin
Dong, Qiang
Tan, Lan
Yu, Jin-Tai
Source :
Journal of Alzheimer's Disease; 2021, Vol. 82 Issue 3, p1045-1054, 10p
Publication Year :
2021

Abstract

<bold>Background: </bold>The relationship between alcohol consumption and Alzheimer's disease (AD) pathology is unclear. Amyloid-β (Aβ) and tau biomarkers in cerebrospinal fluid (CSF) have been proven valuable in establishing prognosis in pre-clinical AD.<bold>Objective: </bold>We sought to examine the associations between alcohol consumption and CSF AD biomarkers in cognitive intact subjects.<bold>Methods: </bold>A total of 806 cognitively intact participants who had measurements of CSF Aβ, pTau, and total Tau proteins and drinking characteristics were included from the Chinese Alzheimer's Biomarker and Lifestyle (CABLE) study. Linear and logistic regression analyses were utilized to explore the associations of alcohol consumption with CSF AD biomarkers. We examined the interaction effects of age, gender, and apolipoprotein epsilon (APOE) ɛ4 status on the relationships between the frequency of drinking and CSF biomarkers.<bold>Results: </bold>The multiple linear regression analyses revealed significant differences in CSF AD biomarkers between infrequent drinking (< 1 times/week) and frequent drinking groups (≥1 times/week). Participants in frequent drinking group had higher CSF p-tau/Aβ42 and tTau/Aβ42. Frequent drinking was significantly associated with greater pTau and tTau abnormalities compared to the infrequent drinking group in older (> 65 years) participants.<bold>Conclusion: </bold>The present study showed significant associations between drinking frequency and CSF AD biomarkers in cognitively intact older adults. Alcohol consumption may have an influence on AD by modulating amyloid deposition and tau phosphorylation in the preclinical stage. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13872877
Volume :
82
Issue :
3
Database :
Complementary Index
Journal :
Journal of Alzheimer's Disease
Publication Type :
Academic Journal
Accession number :
151821268
Full Text :
https://doi.org/10.3233/JAD-210140